Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis

Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

(2020) Kyriakos Souliotis et al.   BMC Endocrine Disorders

Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies

(2020) Constance Stegbauer et al.   BMC HEALTH SERVICES RESEARCH

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

(2019) Thomas Wilke et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Considerations for Initiating a Sodium-Glucose Co-Transporter 2 Inhibitor in Adults With Type 2 Diabetes Using Insulin

(2018) Vincent C. Woo et al.   Canadian Journal of Diabetes

The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece

(2017) Emmanuel Pagkalos et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

7. Obesity Management for the Treatment of Type 2 Diabetes

(2016)   DIABETES CARE

Premixed Insulin Analogue Compared with Basal-Plus Regimen for Inpatient Glycemic Control

(2016) Abraham Edgar Gracia-Ramos et al.   Diabetes Technology & Therapeutics

Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies

(2016) Susanne Ulrich et al.   BMJ Open

Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study

(2016) Sarah E. Holden et al.   PLoS One

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

(2015) J. Vora et al.   DIABETES OBESITY & METABOLISM

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial

(2014) F. J. Tinahones et al.   DIABETES OBESITY & METABOLISM

Real life treatment of diabetes mellitus type 2 patients: An analysis based on a large sample of 394,828 German patients

(2014) Thomas Wilke et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The Clinical Practice Recommendations of the German Diabetes Association

(2014)   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study)

(2014) Grigorios Rombopoulos et al.   Hormones-International Journal of Endocrinology and Metabolism

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

(2014) Conrad Eng et al.   LANCET

Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections

(2013) M. C. Riddle et al.   DIABETES OBESITY & METABOLISM

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes

(2013) Craig J. Currie et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes

(2012) Philip R. Schauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inercia y cumplimiento terapéutico en pacientes con diabetes mellitus tipo 2 en atención primaria

(2011) Flora López-Simarro et al.   MEDICINA CLINICA

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study

(2010) M. L. Norgaard et al.   DIABETOLOGIA

Review on use of German health insurance medication claims data for epidemiological research

(2009) Falk Hoffmann   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Pharmakoepidemiologische Forschung mit Routinedaten des Gesundheitswesens

(2008) Frank Andersohn et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Versorgungsforschung mit GKV-Routinedaten

(2008) Ingrid Schubert et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz